评估基于诊所的干预措施以减少美国人类免疫缺陷病毒感染者死亡率中的种族差异
研究基于1996至2019年进入HIV照护的逾4万黑人和逾3万白人成人,计算观察治疗模式下3年死亡率,并用逆概率权重模拟即时治疗和指南随访等假设干预。观察模式下白人3年死亡率为8%、黑人为9%,差1个百分点(95%CI 0.5-1.4);普遍实施两种干预后差异降至0.2%(95%CI -1.0%至1.4%),而针对黑人重点实施两种干预后黑白差异为-1.4%(95%CI -2.3%至-0.4%)。作者认为聚焦改善黑人患者照护的临床干预可能显著缩小死亡率差距。
要点
- 观察治疗模式下,白人3年死亡率为8%,黑人为9%,绝对差异为1个百分点(95%CI 0.5-1.4)。
- 普遍即时治疗联合指南随访下,黑白3年死亡率差异为0.2%(95%CI -1.0%至1.4%)。
- 重点向黑人患者提供两种干预时,黑白3年死亡率差异为-1.4%(95%CI -2.3%至-0.4%)。
核心结论
- 临床干预,尤其是聚焦改善黑人患者照护的干预,可能显著缩小1996至2019年进入HIV照护的黑人与白人患者之间的死亡率差距。
研究设计与样本
- 研究计算了1996至2019年进入美国HIV照护的逾4万黑人和逾3万白人成人在观察治疗模式下的3年死亡率,并使用逆概率权重模拟假设干预,包括即时治疗和指南随访。
主要发现
- 观察治疗模式下,白人患者3年死亡率为8%,黑人患者为9%,差异为1个百分点(95%CI 0.5-1.4)。
- 普遍即时治疗下,黑白3年死亡率差异降至0.5%(95%CI -0.4%至1.3%)。
- 普遍即时治疗联合指南随访下,黑白3年死亡率差异降至0.2%(95%CI -1.0%至1.4%)。
- 重点向黑人患者提供两种干预而白人患者继续观察治疗模式时,黑白3年死亡率差异为-1.4%(95%CI -2.3%至-0.4%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mortality remains elevated among Black versus White adults receiving human immunodeficiency virus (HIV) care in the United States. We evaluated the effects of hypothetical clinic-based interventions on this mortality gap. METHODS: We computed 3-year mortality under observed treatment patterns among >40 000 Black and >30 000 White adults entering HIV care in the United States from 1996 to 2019. We then used inverse probability weights to impose hypothetical interventions, including immediate treatment and guideline-based follow-up. We considered 2 scenarios: "universal" delivery of interventions to all patients and "focused" delivery of interventions to Black patients while White patients continued to follow observed treatment patterns. RESULTS: Under observed treatment patterns, 3-year mortality was 8% among White patients and 9% among Black patients, for a difference of 1 percentage point (95% confidence interval [CI], .5-1.4). The difference was reduced to 0.5% under universal immediate treatment (95% CI, -.4% to 1.3%) and to 0.2% under universal immediate treatment combined with guideline-based follow-up (95% CI, -1.0% to 1.4%). Under the focused delivery of both interventions to Black patients, the Black-White difference in 3-year mortality was -1.4% (95% CI, -2.3% to -.4%). CONCLUSIONS: Clinical interventions, particularly those focused on enhancing the care of Black patients, could have significantly reduced the mortality gap between Black and White patients entering HIV care from 1996 to 2019.
引用
- Zalla LC, Cole SR, Eron JJ, et al. Evaluating Clinic-Based Interventions to Reduce Racial Differences in Mortality Among People With Human Immunodeficiency Virus in the United States. J Infect Dis. 2023. PMID: 37437108. doi:10.1093/infdis/jiad263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。